Lincoln Financial Life Insurance Fit Review for Epilepsy and Seizure Disorders

Research Snapshot

Why Lincoln Financial Qualified for This Study

Questions This Section Answers

• Why did Lincoln Financial qualify for this epilepsy and seizure disorder life insurance study?
• How often did AI platforms name Lincoln Financial for life insurance with epilepsy?

Lincoln Financial qualified because it cleared the study's two-mention minimum during ranking discovery and because its own published underwriting documents name epilepsy or seizure disorder as a condition the company evaluates. Three of the seven platforms — anthropic, kimi, and perplexity — named Lincoln Financial when asked which carriers are worth considering for applicants with epilepsy or a seizure disorder. That is 42.9% of included platform responses, and it is the only basis for inclusion; the other four platforms did not name the carrier in the ranking stage.

The three naming platforms did not agree on placement. Perplexity ranked Lincoln Financial 4th, kimi 9th, and anthropic 10th, producing an average listed rank of 7.67. Fit ratings split four ways across the full panel: anthropic, google, and kimi rated Lincoln a "good" fit, while openai, deepseek, grok, and perplexity rated it "mixed." That split is the central finding of this review and is carried through every section below.

Qualification here reflects platform visibility and the existence of Lincoln's own seizure-related underwriting language — not demonstrated product superiority. No platform supplied approval rates, average table ratings, or premium data for epilepsy applicants at Lincoln.

The Product, Model, Plan, or Service Most Relevant to Life Insurance for Epilepsy and Seizure Disorders

Questions This Section Answers

• Which Lincoln Financial product should a buyer with epilepsy apply for — TermAccel or LifeElements Level Term?
• Does Lincoln Financial's term life policy let a buyer with a seizure disorder convert to permanent coverage?

The relevant Lincoln products are fully underwritten term life policies — Lincoln TermAccel Level Term and Lincoln LifeElements Level Term — with permanent alternatives in Lincoln's universal, indexed universal, and variable universal life lines. No platform identified an epilepsy-specific Lincoln product, rate class, or guaranteed-issue program.

Lincoln identifies TermAccel Level Term for 10-, 15-, 20-, or 30-year coverage and LifeElements Level Term for coverage amounts of $250,000 and above ^[3]. Both are ordinary medically underwritten options rather than condition-specific products. Lincoln states its term options may be converted to a Lincoln permanent policy subject to applicable policy and conversion rules ^[3]. One platform reported a more specific conversion window: LifeElements Level Term can convert before the end of the level term period or to attained age 70, whichever is earlier ^[4].

The product distinction matters for this buyer. TermAccel is described in Lincoln's own underwriting overview as designed for clients with less complex medical histories ^[5], and it uses a fully electronic process with Tele-App, MIB, Rx, and motor vehicle record checks ^[7]. LifeElements supports more complex underwriting. Because epilepsy or seizure is listed in Lincoln's underwriting materials as a condition that can require labs and vitals ^[8], the accelerated TermAccel pathway may not be available to this applicant — a point the platforms raised repeatedly and that buyers should confirm rather than assume.

What the AI Platforms Agreed About

Questions This Section Answers

• What do AI platforms agree on about Lincoln Financial for epilepsy life insurance underwriting?
• Is Lincoln Financial considered a high-risk or impaired-risk life insurance carrier for seizure disorders?

Four points drew broad agreement across the seven platform responses.

First, Lincoln's published materials treat epilepsy or seizure disorder as a condition subject to structured underwriting review rather than an automatic exclusion. Lincoln's underwriting guide for a life product with a long-term-care rider lists epilepsy or seizure disorder as acceptable within stated conditions: no seizure activity in the prior 12 months, fewer than three medications, and no cognitive or memory-impairment symptoms ^[11]. A separate Lincoln underwriting document lists epilepsy or seizure as a condition that can require laboratory testing and vital signs ^[14].

Second, platforms agreed that seizure history can push an applicant off Lincoln's automated or lab-free pathway. Lincoln describes automated underwriting and possible lab-free processing for qualifying applicants, including certain applicants ages 18 to 60 and coverage amounts up to $2.5 million ^[17], while separately flagging epilepsy as a condition that can prompt labs and vitals ^[14]. One platform stated directly that epilepsy prevents automated lab-free underwriting and routes the file to traditional fully underwritten processing ^[18].

Third, platforms agreed Lincoln offers conventional term coverage in multiple term lengths plus a permanent-policy conversion pathway ^[20].

Fourth, platforms agreed Lincoln holds strong independent financial-strength ratings. Sources cited an A (Excellent) rating from AM Best and A+ from S&P ^[23]. Lincoln's own ratings page confirms its insurance subsidiaries hold independent financial-strength ratings from agencies such as A.M. Best and S&P ^[26]. These ratings speak to claims-paying capacity, not to epilepsy underwriting outcomes.

Where the AI Platforms Disagreed or Were Uncertain

Questions This Section Answers

• Is Lincoln Financial actually good for epilepsy life insurance, or is the evidence too thin to tell?
• Does Lincoln Financial publish epilepsy-specific underwriting guidelines for its term life products?

The panel split on overall fit and left several material questions unresolved.

On fit rating, anthropic, google, and kimi called Lincoln a "good" fit for controlled epilepsy, citing a reputation for favorable epilepsy underwriting ^[27] and inclusion in lists of carriers offering high-risk policies ^[30]. Openai, deepseek, grok, and perplexity called it "mixed," emphasizing that no epilepsy-specific term underwriting rule, rate class, or approval outcome is publicly documented ^[31].

The sharpest unresolved conflict concerns which document governs. The seizure criteria that platforms located — no seizure activity in 12 months, fewer than three medications, no cognitive or memory symptoms — come from a Lincoln MoneyGuard underwriting guide, a life-insurance-with-long-term-care-rider product, not from TermAccel or LifeElements term insurance ^[31]. Openai stated explicitly that these criteria should not be treated as binding for the term products, and perplexity flagged the same mismatch. One platform went further and asserted that epilepsy prevents lab-free underwriting under Lincoln's WealthAccelerate IUL guidelines ^[35] — an indexed universal life product, again not the ranked term policies.

Other unresolved items:

• Whether Lincoln distinguishes idiopathic from secondary epilepsy, or absence from tonic-clonic seizures, in underwriting is not documented in any supplied source ^[37].
• Whether recent medication changes or multiple failed medication trials trigger decline or a table rating is unclear ^[39].
• No platform supplied approval rates, average table ratings, premium surcharges, or claim outcomes for epilepsy applicants at Lincoln ^[31].
• One platform reported that Lincoln's guidelines align with peers offering Table 2–4 ratings for applicants seizure-free 2+ years on medication, and that Lincoln is not the most lenient carrier ^[41]. That is a single platform-reported comparison, not independently verified.

Use-Case-Specific Features and Capabilities

Questions This Section Answers

• What underwriting factors does Lincoln Financial evaluate for an applicant with epilepsy or seizures?
• Does Lincoln Financial offer lab-free or accelerated underwriting to a buyer with a seizure disorder?

Lincoln's relevance to this use case rests on four capabilities, each with a documented caveat.

Structured underwriting that names the condition. Lincoln's published underwriting guide lists epilepsy or seizure disorder with specific conditions attached — no seizure activity in the prior 12 months, fewer than three medications, and no cognitive or memory-impairment symptoms ^[42]. This is company-owned evidence that the condition is reviewed through a defined framework rather than excluded outright. The caveat: the document is a MoneyGuard guide, not a term underwriting grid.

Additional medical review where warranted. Lincoln's underwriting materials list epilepsy or seizure as a condition that can require laboratory testing and vital signs ^[45]. Lincoln also states that underwriting uses medical history and may use pharmacy checks, medical-claims data, and electronic health records ^[48]. The published epilepsy-related guideline specifically references seizure activity, medication count, and cognitive or memory symptoms; no supplied source provides a complete ordinary-term checklist covering seizure type, driving restrictions, neurologist findings, treatment compliance, or time since last seizure ^[42].

Term coverage with conversion. Lincoln offers 10-, 15-, 20-, and 30-year term lengths ^[49] and states term policies may convert to a Lincoln permanent policy ^[50]. One platform reported the LifeElements conversion window as before the end of the level term period or to attained age 70, whichever is earlier ^[52].

Riders relevant to seizure-related risk. One platform reported that Lincoln offers a Waiver of Premium Benefit Rider and an Accelerated Death Benefits rider ^[53]. These are platform-reported and should be confirmed against the issued policy.

Two structural limits apply. Lincoln does not offer whole life insurance ^[54], and product availability varies by state — Lincoln's public term page identifies TermAccel and LifeElements as unavailable in New York, and its variable universal life page notes state-specific availability ^[50]. One platform also reported that lab-free consideration is not available in New York with Lincoln MoneyGuard or Lincoln LifeElements One-Year Term ^[56].

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

• How much does Lincoln Financial life insurance cost per month for a buyer with epilepsy?
• What fees, charges, or cancellation terms apply to a Lincoln Financial policy for someone with a seizure disorder?

No public, applicant-specific premium schedule exists for epilepsy or seizure disorders at Lincoln. Every platform in this study reported low pricing confidence, and no platform supplied a verified rate table, table-rating schedule, or premium figure for this condition.

What the evidence does support:

• Term premiums are quoted individually and depend on age, requested amount and term, state, tobacco status, medical history, underwriting class, and the insurer's assessment of seizure risk ^[57]. Lincoln's public product page does not publish epilepsy-specific rates.
• One platform reported that a standard premium table rating can add 50% to 150% to standard pricing if seizures occurred within the last 12 to 24 months, and that standard rates generally require being seizure-free for 2 to 5 years ^[58]. Another reported table ratings adding roughly 25% per table for less favorable histories ^[60]. These are industry-level, platform-reported figures — not Lincoln-specific quotes.
• Permanent alternatives carry cost-of-insurance, administrative, premium-load, investment or asset-management, and other charges depending on the product ^[61]. Loans and withdrawals can reduce the death benefit and may contribute to lapse, and loan interest may apply ^[63].
• Term coverage lasts for the selected term subject to policy conditions and premium payment; conversion rights and deadlines must be verified in the issued policy ^[57]. Permanent policies may have surrender charges and can lapse if premiums or policy value are insufficient to cover charges ^[62].
• One platform reported no direct application fees to the consumer, with optional riders carrying additional costs ^[64]. Another reported that medical record requests and testing may be required at the underwriter's discretion ^[65].

Multiple independent sources state that Lincoln costs somewhat more than some competitors, with Banner Life and Transamerica cited as lower-cost alternatives ^[66]. One platform framed Lincoln's pricing advantage as coming through favorable underwriting rather than base rates ^[68]. Buyers should treat all of these as platform-reported comparisons requiring a personalized quote.

Best Suited For

Questions This Section Answers

• Who is Lincoln Financial best suited for among life insurance buyers with epilepsy?
• Is Lincoln Financial worth considering for a buyer with well-controlled epilepsy who wants term coverage?

Lincoln Financial is best positioned for applicants with stable, well-documented epilepsy who want conventional fully underwritten term insurance and value a possible conversion to permanent coverage. The platforms converged on a similar profile.

• Applicants seeking 10-, 15-, 20-, or 30-year term coverage who can provide detailed neurologist, medication, seizure-frequency, and treatment records ^[69].
• Applicants whose seizures are stable or absent for a meaningful period and who want a possible conversion option to Lincoln permanent coverage ^[69].
• Applicants needing larger term coverage, where LifeElements Level Term and dedicated large-case underwriting may be relevant ^[69].
• Applicants with moderate-to-complex medical histories who value underwriting flexibility and are willing to complete full medical underwriting ^[71].
• Consumers open to working with a financial professional rather than obtaining quotes online ^[73].

One platform summarized the profile as well-controlled epilepsy with 12+ months seizure-free on a stable low-medication regimen ^[75]. Another framed it as seizure-free 2+ years with stable medications ^[76]. These thresholds are platform-reported and do not come from a published Lincoln term underwriting grid.

Probably Not Best Suited For

Questions This Section Answers

• Who should not choose Lincoln Financial for life insurance with epilepsy or a seizure disorder?
• Is Lincoln Financial a poor choice for a buyer with recent or uncontrolled seizures?

Lincoln Financial is probably not the best fit for applicants whose seizure history is recent, frequent, or poorly documented, or who need a predictable approval decision.

• Applicants with recent, frequent, unexplained, or poorly documented seizures who need predictable approval or a guaranteed price ^[77].
• Applicants seeking no-medical-exam or accelerated underwriting specifically because of seizure history; epilepsy may prompt additional review ^[78].
• Applicants who need the lowest possible impaired-risk premium without an independent comparison among multiple carriers ^[80].
• Buyers recently diagnosed, with frequent or uncontrolled seizures, or with a recent seizure, who are likely to be postponed or declined by a fully underwritten carrier ^[81].
• Buyers who want a no-exam, simplified-issue, or guaranteed-issue policy with a seizure-specific underwriting path ^[81].
• Consumers seeking whole life insurance, which Lincoln does not offer ^[83].
• Buyers who prefer online quote processes and direct enrollment without agent involvement ^[84].

One platform reported that individuals with a diagnosis in the last 6 months or 7+ seizures per year may be limited to final expense insurance ^[87]. That is a platform-reported industry observation, not a Lincoln underwriting rule.

When Another Option May Be Better

Questions This Section Answers

• What is a better alternative to Lincoln Financial for a buyer with uncontrolled seizures who needs guaranteed issue?
• When should a buyer with epilepsy choose a different carrier instead of Lincoln Financial?

Another carrier may be the better choice in five situations the platforms identified.

When the buyer needs guaranteed-issue or simplified-issue coverage. If seizures are recent, frequent, or uncontrolled, final expense or guaranteed-issue carriers may be the only realistic option, with graded benefits and lower face amounts ^[88]. Lincoln is not identified as a leader in that market.

When the buyer's priority is the lowest base rate. Multiple sources name Banner Life and Transamerica as lower-cost than Lincoln for this profile ^[91]. One platform noted Transamerica as more accommodating with certain seizure types ^[93].

When the buyer wants a published, epilepsy-specific underwriting grid before applying. Competitors such as Legal & General and Aviva disclose more detail, including seizure frequency thresholds and consciousness-loss criteria ^[94]. Those are non-U.S. carriers cited as benchmarks, not U.S. purchase options.

When the buyer needs whole life insurance. Lincoln does not offer it; platforms pointed to other carriers for permanent whole life coverage ^[96].

When the buyer needs an expedited no-exam decision. If Lincoln's fully underwritten process would be slower or unavailable for the applicant's history, a carrier with documented accelerated underwriting for controlled epilepsy may serve better ^[97].

Independent consumer guidance supports comparison shopping regardless: applicants with medical conditions should compare multiple insurers and consult an independent agent because underwriting varies by carrier ^[99].

Questions to Verify Before Buying

Questions This Section Answers

• What should a buyer confirm with Lincoln Financial before signing a life insurance contract with epilepsy?
• Which underwriting details must be verified in writing before applying to Lincoln Financial?

The platforms collectively produced a long verification list. The highest-value items:

1. Will Lincoln accept an informal or trial underwriting inquiry before a formal application, and will that inquiry affect future applications ^[100]?
2. For this specific product and state, what seizure-free period, seizure type, medication count, neurologist documentation, and treatment history are required ^[101]?
3. Will driving restrictions, breakthrough seizures, emergency-room visits, EEG or imaging results, or medication changes affect the underwriting class ^[101]?
4. Will the application require an exam, labs, vitals, pharmacy records, medical records, or a personal-history interview ^[104]?
5. What underwriting class, premium, flat extra, exclusion, postponement, or decline is expected based on the applicant's current facts ^[100]?
6. Is TermAccel or LifeElements available in the buyer's state, and which product has the most favorable conversion rights ^[100]?
7. What are the exact conversion deadline, eligible permanent products, conversion pricing basis, and underwriting requirements ^[107]?
8. What are the guaranteed and nonguaranteed premiums, policy fees, rider costs, surrender charges, and lapse assumptions for any permanent alternative ^[108]?
9. How does Lincoln's quote compare with at least two other carriers after identical medical information is submitted ^[100]?
10. Are there any exclusions for seizure-related deaths in the proposed policy ^[111]?

Final AI Consensus Verdict

The consensus verdict is mixed fit. Lincoln Financial is worth a broker-assisted comparison for a consumer with stable, well-documented epilepsy who wants conventional term insurance and values a possible permanent-policy conversion. It is not demonstrated by public evidence to be a best-in-market choice for seizure disorders, because disorder-specific term underwriting rules, pricing, approval outcomes, and current product availability are not publicly disclosed.

The panel split 3–4 on fit rating, and the split tracks evidence quality rather than product quality. Platforms rating Lincoln "good" leaned on its reputation for favorable epilepsy underwriting and its presence on high-risk carrier lists. Platforms rating it "mixed" leaned on the absence of a published epilepsy grid for the term products actually ranked. Both readings are consistent with the same underlying evidence.

The practical conclusion: obtain an informal underwriting assessment, confirm whether the seizure criteria in Lincoln's MoneyGuard guide apply to the term product being considered, and compare competing carriers before applying formally. AI-platform agreement here does not prove product quality, and no platform supplied verified approval or pricing outcomes for this condition.

How This Review Was Produced

This review was produced from a structured multi-platform research run dated 2026-09-22. Seven AI platforms — anthropic, deepseek, google, grok, kimi, openai, and perplexity — were asked which life insurance carriers are generally worth considering for applicants with epilepsy or a seizure disorder, and why. Lincoln Financial was named by three of the seven during ranking discovery, clearing the study's two-mention minimum, and each naming platform supplied a detailed fit assessment, product identification, pricing notes, and verification questions.

The article synthesizes those platform responses, preserves their disagreements, and cites factual claims to the platform-reported sources supplied with each response. Fit ratings, product names, and pricing statements are reported as the platforms stated them. Where a platform supplied no citation for a claim, the claim is labeled platform-reported. This is a fit review of Lincoln Financial for one use case only; it is not a broad company review and does not evaluate Lincoln for other conditions or product lines.

Methodology Limitations

• Platform-reported research dates differ from the authoritative run date. Six platforms reported 2026-09-22; deepseek reported 2026-06-01. Platform-reported dates are provenance metadata and do not independently prove freshness.
• All seven included platforms evaluated fit, but the platform-mention count reflects only the three platforms that named Lincoln Financial during ranking discovery.
• Citations are platform-reported evidence, not independently verified facts. The supplied URLs were collected from platform responses and were not independently validated by the writer stage.
• Deepseek ran with search disabled, so its claims are model-reported rather than retrieved and require explicit verification before being treated as current facts.
• Conflicting product names, pricing, and capabilities were not resolved by guessing. Where sources conflicted — most notably whether the MoneyGuard seizure criteria apply to Lincoln's term products — the conflict is described and the buyer is directed to verify.
• No platform supplied approval rates, average table ratings, premium surcharges, or claim outcomes for epilepsy applicants at Lincoln. No reliable public evidence was found for these figures.
• The seizure-related criteria located publicly come from a Lincoln MoneyGuard underwriting guide, not expressly from TermAccel or LifeElements term insurance.
• Current product availability, policy forms, conversion provisions, rider charges, and underwriting rules may vary by state and may change.
• This review does not constitute medical, financial, or insurance advice, and it does not claim personal testing, customer experience, or independent verification of any carrier outcome.

See the broader Life Insurance for Epilepsy and Seizure Disorders consensus index for comparisons across qualified options.